Drug Trial Radar · NCT03460652
KP415 Open-Label Safety Study in Children (6-12 Years of Age) With ADHD
Last checked: Nov 19, 2026Latest source record: Jul 19, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
282
Actual
Start
Mar 13, 2018
Primary completion
Jun 20, 2019
Study completion Jul 9, 2019
Sponsor
- Lead sponsor
- Zevra TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Mar 9, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 6 years, up to 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a multicenter, dose-optimized, open-label safety study with KP415 in children with Attention-Deficit/Hyperactivity Disorder (ADHD).
Conditions
- ADHD
Interventions
KP415 oral capsuleDrug
Once-daily oral dose
Primary outcomes
What the sponsor says the trial is designed to measure.
- Subjects With Treatment-Emergent Adverse Events (TEAEs)Time frame: Up to 12 months
Locations
19 sites in 1 country. Site status is shown where the registry gives one.
Woodland International Research
Little Rock, Arkansas
MCB Clinical Research Centers
Colorado Springs, Colorado
Meridien Research
Bradenton, Florida
Clinical Neuroscience Solutions, Inc.
Jacksonville, Florida
Innovative Clinical Research, Inc.
Lauderhill, Florida
Meridien Research
Maitland, Florida
Clinical Neuroscience Solutions, Inc.
Orlando, Florida
Capstone Clinical Research
Libertyville, Illinois
Psychiatric Associates
Overland Park, Kansas
Center for Psychiatry and Behavioral Medicine, Inc.
Las Vegas, Nevada
Hassman Research Institute
Berlin, New Jersey
Neuro-Behavioral Clinical Research
Canton, Ohio
Midwest Clinical Research Center, LLC
Dayton, Ohio
Oregon Center for Clinical Investigations, Inc.
Portland, Oregon
Oregon Center for Clinical Investigations, Inc.
Salem, Oregon
Clinical Neuroscience Solutions, Inc.
Memphis, Tennessee
FutureSearch Trials
Austin, Texas
Bayou City Research, Ltd.
Houston, Texas
Houston Clinical Trials
Houston, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.